Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
7,92 USD | +1,41% | +4,21% | +5,21% |
Attività
Numero di dipendenti: 121
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Gene Therapeutics
100,0
%
| 0 | nan % | 4 | 100,0 % | - |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 0 | nan % | 4 | 100,0 % | - |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Laurent Fischer
CEO | Chief Executive Officer | 60 | 15/06/20 |
Linda Rubinstein
DFI | Director of Finance/CFO | 58 | 12/12/22 |
Bill Tan
CTO | Chief Tech/Sci/R&D Officer | - | 01/03/21 |
Romuald Corbau
CTO | Chief Tech/Sci/R&D Officer | 55 | 29/01 |
Peter Soparkar
COO | Chief Operating Officer | 53 | 30/10/19 |
R. Ramelmeier
CTO | Chief Tech/Sci/R&D Officer | 62 | 21/08/23 |
Anand Reddi
HRO | Human Resources Officer | 42 | - |
Star Seyedkazemi
PRN | Corporate Officer/Principal | 50 | 06/01/22 |
Corporate Officer/Principal | - | 25/06/20 | |
Dena House
HRO | Human Resources Officer | - | 01/07/19 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Scott Whitcup
BRD | Director/Board Member | 64 | 16/04/20 |
Clarence Machado
CHM | Chairman | 60 | 14/03/17 |
Laurent Fischer
CEO | Chief Executive Officer | 60 | 15/06/20 |
Jim Scopa
BRD | Director/Board Member | 65 | 01/05/19 |
C. Nicholson
BRD | Director/Board Member | 68 | 03/11 |
Mark Lupher
BRD | Director/Board Member | 53 | 01/05/19 |
Reed Tuckson
BRD | Director/Board Member | 73 | 19/02/21 |
Dawn Svoronos
BRD | Director/Board Member | 70 | 09/12/20 |
Rabia Ozden
BRD | Director/Board Member | 56 | 17/03/22 |
Soo Hong
BRD | Director/Board Member | 52 | 17/03/22 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 20 756 850 | 20 386 246 ( 98,21 %) | 0 | 98,21 % |
Coordinate società
Settore
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
+5,21% | 164 Mln | |
+11,60% | 106 Mrd | |
-4,68% | 24,28 Mrd | |
-0,82% | 21,96 Mrd | |
-10,12% | 18,16 Mrd | |
-42,12% | 16,37 Mrd | |
-17,47% | 15,56 Mrd | |
+2,77% | 13,63 Mrd | |
+34,58% | 12,27 Mrd | |
+77,64% | 8,87 Mrd |
- Borsa valori
- Azioni
- Azione ADVM
- Società Adverum Biotechnologies, Inc.